Literature DB >> 28031368

The Structural Interface between HIV-1 Vif and Human APOBEC3H.

Marcel Ooms1, Michael Letko2,3, Viviana Simon1,4,5.   

Abstract

Human APOBEC3H (A3H) is a cytidine deaminase that inhibits HIV-1 replication. To evade this restriction, the HIV-1 Vif protein binds A3H and mediates its proteasomal degradation. To date, little information on the Vif-A3H interface has been available. To decipher how both proteins interact, we first mapped the Vif-binding site on A3H by functionally testing a large set of A3H mutants in single-cycle infectivity and replication assays. Our data show that the two A3H α-helixes α3 and α4 represent the Vif-binding site of A3H. We next used viral adaptation and a set of Vif mutants to identify novel, reciprocal Vif variants that rescued viral infectivity in the presence of two Vif-resistant A3H mutants. These A3H-Vif interaction points were used to generate the first A3H-Vif structure model, which revealed that the A3H helixes α3 and α4 interact with the Vif β-sheet (β2-β5). This model is in good agreement with previously reported Vif and A3H amino acids important for interaction. Based on the predicted A3H-Vif interface, we tested additional points of contact, which validated our model. Moreover, these experiments showed that the A3H and A3G binding sites on HIV-1 Vif are largely distinct, with both host proteins interacting with Vif β-strand 2. Taken together, this virus-host interface model explains previously reported data and will help to identify novel drug targets to combat HIV-1 infection.IMPORTANCE HIV-1 needs to overcome several intracellular restriction factors in order to replicate efficiently. The human APOBEC3 locus encodes seven proteins, of which A3D, A3F, A3G, and A3H restrict HIV-1. HIV encodes the Vif protein, which binds to the APOBEC3 proteins and leads to their proteasomal degradation. No HIV-1 Vif-APOBEC3 costructure exists to date despite extensive research. We and others previously generated HIV-1 Vif costructure models with A3G and A3F by mapping specific contact points between both proteins. Here, we applied a similar approach to HIV-1 Vif and A3H and successfully generated a Vif-A3H interaction model. Importantly, we find that the HIV-1 Vif-A3H interface is distinct from the Vif-A3G and Vif-A3F interfaces, with a small Vif region being important for recognition of both A3G and A3H. Our Vif-A3H structure model informs on how both proteins interact and could guide toward approaches to block the Vif-A3H interface to target HIV replication.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  A3H; APOBEC3; APOBEC3H; HIV; HIV-1; Vif; restriction factor

Mesh:

Substances:

Year:  2017        PMID: 28031368      PMCID: PMC5309942          DOI: 10.1128/JVI.02289-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

Review 2.  Intrinsic host restrictions to HIV-1 and mechanisms of viral escape.

Authors:  Viviana Simon; Nicolin Bloch; Nathaniel R Landau
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

3.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

4.  A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.

Authors:  Anjie Zhen; Tao Wang; Ke Zhao; Yong Xiong; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

5.  Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.

Authors:  Rebecca A Russell; Jessica Smith; Rebekah Barr; Darshana Bhattacharyya; Vinay K Pathak
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

6.  Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.

Authors:  Rebecca A Russell; Vinay K Pathak
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

7.  HIV-1 Vif adaptation to human APOBEC3H haplotypes.

Authors:  Marcel Ooms; Bonnie Brayton; Michael Letko; Susan M Maio; Christopher D Pilcher; Frederick M Hecht; Jason D Barbour; Viviana Simon
Journal:  Cell Host Microbe       Date:  2013-10-16       Impact factor: 21.023

8.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.

Authors:  Hui Zhang; Bin Yang; Roger J Pomerantz; Chune Zhang; Shyamala C Arunachalam; Ling Gao
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

9.  APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model.

Authors:  Kei Sato; Junko S Takeuchi; Naoko Misawa; Taisuke Izumi; Tomoko Kobayashi; Yuichi Kimura; Shingo Iwami; Akifumi Takaori-Kondo; Wei-Shau Hu; Kazuyuki Aihara; Mamoru Ito; Dong Sung An; Vinay K Pathak; Yoshio Koyanagi
Journal:  PLoS Pathog       Date:  2014-10-16       Impact factor: 6.823

10.  The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif.

Authors:  Marcel Ooms; Michael Letko; Mawuena Binka; Viviana Simon
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more
  15 in total

1.  Recurrent Loss of APOBEC3H Activity during Primate Evolution.

Authors:  Erin I Garcia; Michael Emerman
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 2.  Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions.

Authors:  Farshad C Azimi; Jeffrey E Lee
Journal:  Protein Sci       Date:  2019-11-29       Impact factor: 6.725

3.  Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.

Authors:  Jiayi Wang; Nadine M Shaban; Allison M Land; William L Brown; Reuben S Harris
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

4.  Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s.

Authors:  Yingxia Hu; Kirsten M Knecht; Qi Shen; Yong Xiong
Journal:  FEBS J       Date:  2020-09-21       Impact factor: 5.542

5.  The Role of RNA in HIV-1 Vif-Mediated Degradation of APOBEC3H.

Authors:  Jiayi Wang; Jordan T Becker; Ke Shi; Kate V Lauer; Daniel J Salamango; Hideki Aihara; Nadine M Shaban; Reuben S Harris
Journal:  J Mol Biol       Date:  2019-10-16       Impact factor: 5.469

6.  Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated Using Patient HIV-1 Isolates and Computational Modeling.

Authors:  Daniel J Salamango; Jennifer L McCann; Özlem Demir; Jordan T Becker; Jiayi Wang; Jairam R Lingappa; Nuri A Temiz; William L Brown; Rommie E Amaro; Reuben S Harris
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

7.  Stably expressed APOBEC3H forms a barrier for cross-species transmission of simian immunodeficiency virus of chimpanzee to humans.

Authors:  Zeli Zhang; Qinyong Gu; Marc de Manuel Montero; Ignacio G Bravo; Tomas Marques-Bonet; Dieter Häussinger; Carsten Münk
Journal:  PLoS Pathog       Date:  2017-12-21       Impact factor: 6.823

8.  APOBEC3H structure reveals an unusual mechanism of interaction with duplex RNA.

Authors:  Jennifer A Bohn; Keyur Thummar; Ashley York; Alice Raymond; W Clay Brown; Paul D Bieniasz; Theodora Hatziioannou; Janet L Smith
Journal:  Nat Commun       Date:  2017-10-18       Impact factor: 14.919

Review 9.  Structural Insights into APOBEC3-Mediated Lentiviral Restriction.

Authors:  Krista A Delviks-Frankenberry; Belete A Desimmie; Vinay K Pathak
Journal:  Viruses       Date:  2020-05-27       Impact factor: 5.048

10.  Structural basis of chimpanzee APOBEC3H dimerization stabilized by double-stranded RNA.

Authors:  Tatsuya Matsuoka; Takayuki Nagae; Hirotaka Ode; Hiroaki Awazu; Teppei Kurosawa; Akiko Hamano; Kazuhiro Matsuoka; Atsuko Hachiya; Mayumi Imahashi; Yoshiyuki Yokomaku; Nobuhisa Watanabe; Yasumasa Iwatani
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.